Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.4	46.33	69.55	34.27	15.75	10.69
Short-Term Investments	-	-	-	-	54.6	54.78
Cash & Short-Term Investments	15.4	46.33	69.55	34.27	70.35	65.47
Cash Growth	-51.78%	-33.38%	102.92%	-51.29%	7.46%	5.57%
Receivables	17.37	0.08	4.42	0.49	-	-
Inventory	2.52	2.46	1.02	-	-	-
Prepaid Expenses	1.49	2.31	2.55	4.36	3.97	2.18
Total Current Assets	36.78	51.18	77.53	39.12	74.33	67.65
Property, Plant & Equipment	1.95	2.58	3.62	5.33	5.5	4.94
Long-Term Deferred Charges	-	-	-	-	-	0.1
Other Long-Term Assets	0.38	0.38	0.45	0.28	0.3	1.47
Total Assets	39.11	54.13	81.6	44.72	80.13	74.15
Accounts Payable	2.32	1.9	2.46	0.51	0.85	0.35
Accrued Expenses	3.13	3.09	8.17	2.43	3.01	2.84
Short-Term Debt	-	-	-	-	41.69	35.32
Current Portion of Long-Term Debt	12.67	12.94	-	-	-	-
Current Portion of Leases	0.65	0.67	0.7	0.3	0.25	0.2
Current Unearned Revenue	0.48	-	-	-	-	0.5
Other Current Liabilities	9.98	10.42	5.69	0.22	0.26	0.28
Total Current Liabilities	29.22	29.01	17.02	3.46	46.06	39.48
Long-Term Debt	24.58	30.98	42.87	-	-	-
Long-Term Leases	1	1.35	1.94	1.23	1.47	1.69
Other Long-Term Liabilities	1.8	2.65	-	-	-	-
Total Liabilities	56.59	63.99	61.83	4.69	47.52	41.17
Common Stock	0	0.01	0	0	0	0
Additional Paid-In Capital	299.08	297.16	250.21	203.48	171.6	136.87
Retained Earnings	-316.57	-307.03	-230.45	-163.45	-138.97	-103.89
Comprehensive Income & Other	-	-	-	-	-0.03	0
Total Common Equity	-17.48	-9.86	19.76	40.03	32.61	32.99
Shareholders' Equity	-17.48	-9.86	19.76	40.03	32.61	32.99
Total Liabilities & Equity	39.11	54.13	81.6	44.72	80.13	74.15
Total Debt	38.89	45.94	45.51	1.53	43.41	37.21
Net Cash (Debt)	-23.5	0.39	24.04	32.75	26.95	28.26
Net Cash Growth	-	-98.38%	-26.60%	21.53%	-4.67%	-54.29%
Net Cash Per Share	-3.09	0.08	5.30	9.59	9.96	11.31
Filing Date Shares Outstanding	9.45	9.18	4.24	4.19	2.75	2.54
Total Common Shares Outstanding	9.25	9.18	4.24	4.11	2.75	2.54
Working Capital	7.56	22.17	60.51	35.66	28.27	28.18
Book Value Per Share	-1.89	-1.07	4.66	9.74	11.85	12.97
Tangible Book Value	-17.48	-9.86	19.76	40.03	32.61	32.99
Tangible Book Value Per Share	-1.89	-1.07	4.66	9.74	11.85	12.97
Machinery	1.37	1.79	2.17	2	1.37	0.27
Construction In Progress	-	-	-	2.54	2.73	2.86
Leasehold Improvements	0.05	0.05	0.05	0.05	0.05	0.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q